What is the ticker symbol for Acorda Therapeutics?

Acorda Therapeutics trades under the ticker ACOR on NASDAQ.

What sector does Acorda Therapeutics operate in?

Acorda Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze ACOR in a portfolio?

PortView shows ACOR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Acorda Therapeutics (ACOR) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$0.66-24.02%

1-year price historyRange $0.09 – $0.90

52-week range$0.66

$0.61$24.20

What Acorda Therapeutics does

Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.

Key metrics

Market cap

$821,028

P/E (TTM)

-0.00

EPS (TTM)

$-203.57

Beta

1.46

Dividend yield

0.00%

Revenue / share

$94.71

50-day avg

$12.10

200-day avg

$13.17

52-week high

$24.20

52-week low

$0.61

CEO

Ron Cohen

ETFs linked to ACOR

Broad-market and Healthcare sector ETFs an investor holding Acorda Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ACOR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ACOR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Acorda Therapeutics?: Acorda Therapeutics trades under the ticker ACOR on NASDAQ.
Which exchange is ACOR listed on?: ACOR is listed on NASDAQ.
What sector does Acorda Therapeutics operate in?: Acorda Therapeutics is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze ACOR in a portfolio?: PortView shows ACOR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.